Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Supercooling extends preservation time of human livers.

de Vries RJ, Tessier SN, Banik PD, Nagpal S, Cronin SEJ, Ozer S, Hafiz EOA, van Gulik TM, Yarmush ML, Markmann JF, Toner M, Yeh H, Uygun K.

Nat Biotechnol. 2019 Sep 9. doi: 10.1038/s41587-019-0223-y. [Epub ahead of print]

PMID:
31501557
2.

Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation.

Fu Q, Yang F, Liao M, Feeney NJ, Deng K, Serifis N, Wei L, Yang H, Chen K, Deng S, Markmann JF.

Front Oncol. 2019 Aug 7;9:737. doi: 10.3389/fonc.2019.00737. eCollection 2019.

3.

Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.

Fu Q, Liao M, Feng C, Tang J, Liao R, Wei L, Yang H, Markmann JF, Chen K, Deng S.

Aging (Albany NY). 2019 Jul 25;11(14):5215-5231. doi: 10.18632/aging.102115.

4.

Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.

Firl DJ, Sasaki K, Agopian VG, Gorgen A, Kimura S, Dumronggittigule W, McVey JC, Iesari S, Mennini G, Vitale A, Finkenstedt A, Onali S, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Agnes S, Vivarelli M, Tisone G, Ettorre GM, Otto G, Tsochatzis E, Rossi M, Viveiros A, Cillo U, Markmann JF, Ikegami T, Kaido T, Lai Q, Sapisochin G, Lerut J; European Hepatocellular Cancer Liver Transplant Study Group, Aucejo FN.

Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838. [Epub ahead of print]

PMID:
31243778
5.

Trapped Chromatin Fibers Damage Flowing Red Blood Cells.

Roushan M, Jorfi M, Mishra A, Wong KHK, Jorgensen J, Ell E, Markmann JF, Lee J, Irimia D.

Adv Biosyst. 2018 Oct;2(10). pii: 1800040. doi: 10.1002/adbi.201800040. Epub 2018 Aug 12.

6.

Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets.

Tanimine N, Germana SK, Fan M, Hippen K, Blazar BR, Markmann JF, Turka LA, Priyadharshini B.

PLoS One. 2019 Jun 6;14(6):e0217761. doi: 10.1371/journal.pone.0217761. eCollection 2019.

7.

Current state of organ transplant tolerance.

Rickert CG, Markmann JF.

Curr Opin Organ Transplant. 2019 Aug;24(4):441-450. doi: 10.1097/MOT.0000000000000670.

PMID:
31169530
8.

Rehabilitation of Discarded Steatotic Livers Using Ex Situ Normothermic Machine Perfusion: A Future Source of Livers for Transplantation.

Raigani S, Markmann JF, Yeh H.

Liver Transpl. 2019 Jul;25(7):991-992. doi: 10.1002/lt.25490. No abstract available.

PMID:
31077626
9.

Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro.

Jones CN, Ellett F, Robertson AL, Forrest KM, Judice K, Balkovec JM, Springer M, Markmann JF, Vyas JM, Warren HS, Irimia D.

Front Immunol. 2019 Apr 9;10:644. doi: 10.3389/fimmu.2019.00644. eCollection 2019.

10.

Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion.

Aburawi MM, Fontan FM, Karimian N, Eymard C, Cronin S, Pendexter C, Nagpal S, Banik P, Ozer S, Mahboub P, Delmonico FL, Yeh H, Uygun K, Markmann JF.

Am J Transplant. 2019 Apr 2. doi: 10.1111/ajt.15375. [Epub ahead of print]

PMID:
30938927
11.

Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium.

DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG.

Ann Surg. 2019 Mar 5. doi: 10.1097/SLA.0000000000003253. [Epub ahead of print]

PMID:
30870180
12.

Alginate-microencapsulation of human stem cell-derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression.

Alagpulinsa DA, Cao JJL, Driscoll RK, Sîrbulescu RF, Penson MFE, Sremac M, Engquist EN, Brauns TA, Markmann JF, Melton DA, Poznansky MC.

Am J Transplant. 2019 Jul;19(7):1930-1940. doi: 10.1111/ajt.15308. Epub 2019 Mar 25.

PMID:
30748094
13.

Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model.

Navarro-Alvarez N, Machaidze Z, Schuetz C, Zhu A, Liu WH, Shah JA, Vagefi PA, Elias N, Buhler L, Sachs DH, Markmann JF, Yeh H.

PLoS One. 2018 Nov 21;13(11):e0207272. doi: 10.1371/journal.pone.0207272. eCollection 2018.

14.

Oxygenated UW Solution Decreases ATP Decay and Improves Survival After Transplantation of DCD Liver Grafts.

Martins PN, Berendsen TA, Yeh H, Bruinsma BG, Izamis ML, Op den Dries S, Gillooly AR, Porte R, Yarmush ML, Uygun K, Markmann JF.

Transplantation. 2019 Feb;103(2):363-370. doi: 10.1097/TP.0000000000002530.

PMID:
30422952
15.

Hepatocellular Carcinoma in Transplantable Child-Pugh A Cirrhotics: Should Cost Affect Resection vs Transplantation?

Michelakos T, Xourafas D, Qadan M, Pieretti-Vanmarcke R, Cai L, Patel MS, Adler JT, Fontan F, Basit U, Vagefi PA, Elias N, Tanabe KK, Berger D, Yeh H, Markmann JF, Chang DC, Ferrone CR.

J Gastrointest Surg. 2019 Jun;23(6):1135-1142. doi: 10.1007/s11605-018-3946-z. Epub 2018 Sep 14.

PMID:
30218342
16.

Heat Stroke as a Cause of Liver Failure and Evaluation of Liver Transplant.

Martins PN, Brüggenwirth IMA, McDaid J, Hertl M, Kawai T, Elias N, Chung RT, Markmann JF.

Exp Clin Transplant. 2018 Aug 17. doi: 10.6002/ect.2018.0003. [Epub ahead of print]

17.

Endothelial Dysfunction in Steatotic Human Donor Livers: A Pilot Study of the Underlying Mechanism During Subnormothermic Machine Perfusion.

Beijert I, Mert S, Huang V, Karimian N, Geerts S, Hafiz EOA, Markmann JF, Yeh H, Porte RJ, Uygun K.

Transplant Direct. 2018 Apr 23;4(5):e345. doi: 10.1097/TXD.0000000000000779. eCollection 2018 May.

18.

Normothermic liver preservation, current status and future directions.

Detelich D, Markmann JF.

Curr Opin Organ Transplant. 2018 Jun;23(3):347-352. doi: 10.1097/MOT.0000000000000531. Review.

PMID:
29629996
19.

Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.

Firl DJ, Kimura S, McVey J, Hashimoto K, Yeh H, Miller CM, Markmann JF, Sasaki K, Aucejo FN.

Hepatology. 2018 Oct;68(4):1448-1458. doi: 10.1002/hep.29907.

PMID:
29604231
20.

Relaxing liver ischemia reperfusion injury down 1 notch.

Markmann JF.

Am J Transplant. 2018 Jul;18(7):1587-1588. doi: 10.1111/ajt.14741. Epub 2018 Apr 17. No abstract available.

21.

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transplantation. 2018 Sep;102(9):1479-1486. doi: 10.1097/TP.0000000000002158. Review.

22.

Defining outcomes for beta cell replacement therapy: a work in progress.

Piemonti L, de Koning EJP, Berney T, Odorico JS, Markmann JF, Stock PG, Rickels MR.

Diabetologia. 2018 Jun;61(6):1273-1276. doi: 10.1007/s00125-018-4588-0. Epub 2018 Mar 6.

23.

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transpl Int. 2018 Apr;31(4):343-352. doi: 10.1111/tri.13138. Review.

24.

Commentary on Nurse Telephonic Triage Service for After-hour Patient Calls in Neurosurgery.

Markmann JF.

Ann Surg. 2018 Apr;267(4):e69. doi: 10.1097/SLA.0000000000002680. No abstract available.

PMID:
29401108
25.

The dawn of liver perfusion machines.

Detelich D, Markmann JF.

Curr Opin Organ Transplant. 2018 Apr;23(2):151-161. doi: 10.1097/MOT.0000000000000500. Review.

26.

Pediatric kidney transplantation and mortality: Distance to transplant center matters.

Cao B, Adler JT, Bababekov YJ, Markmann JF, Chang DC, Yeh H.

Pediatr Transplant. 2018 Mar;22(2). doi: 10.1111/petr.13120. Epub 2018 Jan 7.

PMID:
29316061
27.

A novel model for ex situ reperfusion of the human liver following subnormothermic machine perfusion.

Avruch JH, Bruinsma BG, Weeder PD, Sridharan GV, Porte RJ, Yeh H, Markmann JF, Uygun K.

Technology (Singap World Sci). 2017 Dec;5(4):196-200. doi: 10.1142/S2339547817500108. Epub 2017 Nov 10.

28.

Erratum. National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities. Diabetes 2016;65:3418-3428.

Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant DE, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Friberg AS, Lei J, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AMJ.

Diabetes. 2017 Sep;66(9):2531. doi: 10.2337/db17-er09a. Epub 2017 Jun 29. No abstract available.

29.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW.

Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381.

PMID:
28654545
30.

The promise of organ and tissue preservation to transform medicine.

Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M.

Nat Biotechnol. 2017 Jun 7;35(6):530-542. doi: 10.1038/nbt.3889. Review.

31.

Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade.

Shah JA, Patel MS, Elias N, Navarro-Alvarez N, Rosales I, Wilkinson RA, Louras NJ, Hertl M, Fishman JA, Colvin RB, Cosimi AB, Markmann JF, Sachs DH, Vagefi PA.

Am J Transplant. 2017 Aug;17(8):2178-2185. doi: 10.1111/ajt.14341. Epub 2017 Jun 6.

32.

Islet cell transplant: Update on current clinical trials.

Schuetz C, Markmann JF.

Curr Transplant Rep. 2016 Sep;3(3):254-263. doi: 10.1007/s40472-016-0103-z. Epub 2016 May 17.

33.

Regulatory B Cell-Dependent Islet Transplant Tolerance Is Also Natural Killer Cell Dependent.

Schuetz C, Lee KM, Scott R, Kojima L, Washburn L, Liu L, Liu WH, Tector H, Lei J, Yeh H, Kim JI, Markmann JF.

Am J Transplant. 2017 Jun;17(6):1656-1662. doi: 10.1111/ajt.14265. Epub 2017 Apr 11.

34.

Testing of microencapsulated porcine hepatocytes in a new model of fulminant liver failure in baboons.

Machaidze Z, Yeh H, Wei L, Schuetz C, Carvello M, Sgroi A, Smith RN, Schuurman HJ, Sachs DH, Morel P, Markmann JF, Bühler LH.

Xenotransplantation. 2017 May;24(3). doi: 10.1111/xen.12297. Epub 2017 Mar 5.

PMID:
28261903
35.

Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report.

Villani V, Gupta N, Elias N, Vagefi PA, Markmann JF, Paul E, Traum AZ, Yeh H.

Pediatr Transplant. 2017 May;21(3). doi: 10.1111/petr.12901. Epub 2017 Mar 5.

PMID:
28261895
36.

Peritransplant Energy Changes and Their Correlation to Outcome After Human Liver Transplantation.

Bruinsma BG, Avruch JH, Sridharan GV, Weeder PD, Jacobs ML, Crisalli K, Amundsen B, Porte RJ, Markmann JF, Uygun K, Yeh H.

Transplantation. 2017 Jul;101(7):1637-1644. doi: 10.1097/TP.0000000000001699.

37.

Interpreting Outcomes in DCDD Liver Transplantation: First Report of the Multicenter IDOL Consortium.

Goldberg DS, Karp SJ, McCauley ME, Markmann JF, Croome KP, Taner CB, Heimbach JK, Leise MD, Fryer JP, Bohorquez HE, Cohen AJ, Gilroy RK, Kumer SC, Foley DP, Karim AS, Hernandez-Alejandro R, Levstik MA, Abt PL.

Transplantation. 2017 May;101(5):1067-1073. doi: 10.1097/TP.0000000000001656.

PMID:
28114173
38.

Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide.

NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee, Ansite J, Balamurugan AN, Barbaro B, Battle J, Brandhorst D, Cano J, Chen X, Deng S, Feddersen D, Friberg A, Gilmore T, Goldstein JS, Holbrook E, Khan A, Kin T, Lei J, Linetsky E, Liu C, Luo X, McElvaney K, Min Z, Moreno J, O'Gorman D, Papas KK, Putz G, Ricordi C, Szot G, Templeton T, Wang L, Wilhelm JJ, Willits J, Wilson T, Zhang X; NIH CIT Consortium, Avila J, Begley B, Cano J, Carpentier S, Holbrook E, Hutchinson J, Larsen CP, Moreno J, Sears M, Turgeon NA, Webster D, Deng S, Lei J, Markmann JF, Bridges ND, Czarniecki CW, Goldstein JS, Putz G, Templeton T, Wilson T, Eggerman TL, Al-Saden P, Battle J, Chen X, Hecyk A, Kissler H, Luo X, Molitch M, Monson N, Stuart E, Wallia A, Wang L, Wang S, Zhang X, Bigam D, Campbell P, Dinyari P, Kin T, Kneteman N, Lyon J, Malcolm A, O'Gorman D, Onderka C, Owen R, Pawlick R, Richer B, Rosichuk S, Sarman D, Schroeder A, Senior PA, Shapiro AMJ, Toth L, Toth V, Zhai W, Johnson K, McElroy J, Posselt AM, Ramos M, Rojas T, Stock PG, Szot G, Barbaro B, Martellotto J, Oberholzer J, Qi M, Wang Y, Bayman L, Chaloner K, Clarke W, Dillon JS, Diltz C, Doelle GC, Ecklund D, Feddersen D, Foster E, Hunsicker LG, Jasperson C, Lafontant DE, McElvaney K, Neill-Hudson T, Nollen D, Qidwai J, Riss H, Schwieger T, Willits J, Yankey J, Alejandro R, Corrales AC, Faradji R, Froud T, Garcia AA, Herrada E, Ichii H, Inverardi L, Kenyon N, Khan A, Linetsky E, Montelongo J, Peixoto E, Peterson K, Ricordi C, Szust J, Wang X, Abdulla MH, Ansite J, Balamurugan AN, Bellin MD, Brandenburg M, Gilmore T, Harmon JV, Hering BJ, Kandaswamy R, Loganathan G, Mueller K, Papas KK, Pedersen J, Wilhelm JJ, Witson J, Dalton-Bakes C, Fu H, Kamoun M, Kearns J, Li Y, Liu C, Luning-Prak E, Luo Y, Markmann E, Min Z, Naji A, Palanjian M, Rickels M, Shlansky-Goldberg R, Vivek K, Ziaie AS, Fernandez L, Kaufman DB, Zitur L, Brandhorst D, Friberg A, Korsgren O.

CellR4 Repair Replace Regen Reprogram. 2017;5(3). pii: e2377. Epub 2017 May 26. No abstract available.

39.

Donor exosomes rather than passenger leukocytes initiate alloreactive T cell responses after transplantation.

Marino J, Babiker-Mohamed MH, Crosby-Bertorini P, Paster JT, LeGuern C, Germana S, Abdi R, Uehara M, Kim JI, Markmann JF, Tocco G, Benichou G.

Sci Immunol. 2016 Jul 14;1(1). pii: aaf8759.

40.

Distance is associated with mortality on the waitlist in pediatric liver transplantation.

Adler JT, Bababekov YJ, Markmann JF, Chang DC, Yeh H.

Pediatr Transplant. 2017 Mar;21(2). doi: 10.1111/petr.12842. Epub 2016 Nov 1.

PMID:
27804189
41.

 High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.

Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA.

Ann Hepatol. 2016 Nov-Dec 2016;15(6):888-894.

42.

Readmission following liver transplantation: an unwanted occurrence but an opportunity to act.

Patel MS, Mohebali J, Shah JA, Markmann JF, Vagefi PA.

HPB (Oxford). 2016 Nov;18(11):936-942. doi: 10.1016/j.hpb.2016.08.003. Epub 2016 Sep 15.

43.

Signatures of Tolerance or Immunosuppression?

Markmann JF.

Am J Transplant. 2016 Dec;16(12):3320-3321. doi: 10.1111/ajt.13993. Epub 2016 Aug 24. No abstract available.

44.

National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities.

Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant DE, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Chen X, Friberg AS, Lei J, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AM, Chen X.

Diabetes. 2016 Nov;65(11):3418-3428. Epub 2016 Jul 27. Erratum in: Diabetes. 2017 Sep;66(9):2531.

45.

The Beginnings of a Transplant Revolution.

Markmann JF, Yeh H.

Ann Surg. 2017 Jan;265(1):e3. doi: 10.1097/SLA.0000000000001947. No abstract available.

PMID:
27464619
46.

A reliable scoring system after major liver resection in mice.

Xu Y, Navarro-Alvarez N, Yang C, Markmann JF, Dong J, Yeh H.

J Surg Res. 2016 Jul;204(1):75-82. doi: 10.1016/j.jss.2016.03.066. Epub 2016 Apr 9.

PMID:
27451871
47.

Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients.

Madariaga ML, Spencer PJ, Shanmugarajah K, Crisalli KA, Chang DC, Markmann JF, Elias N, Cosimi AB, Sachs DH, Kawai T.

JCI Insight. 2016 Jun 2;1(8). pii: e87019.

48.

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia.

Hering BJ, Clarke WR, Bridges ND, Eggerman TL, Alejandro R, Bellin MD, Chaloner K, Czarniecki CW, Goldstein JS, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Markmann JF, Naji A, Oberholzer J, Posselt AM, Rickels MR, Ricordi C, Robien MA, Senior PA, Shapiro AM, Stock PG, Turgeon NA; Clinical Islet Transplantation Consortium.

Diabetes Care. 2016 Jul;39(7):1230-40. doi: 10.2337/dc15-1988. Epub 2016 Apr 18.

49.

Machine Perfusion of Donor Livers for Transplantation: A Proposal for Standardized Nomenclature and Reporting Guidelines.

Karangwa SA, Dutkowski P, Fontes P, Friend PJ, Guarrera JV, Markmann JF, Mergental H, Minor T, Quintini C, Selzner M, Uygun K, Watson CJ, Porte RJ.

Am J Transplant. 2016 Oct;16(10):2932-2942. doi: 10.1111/ajt.13843. Epub 2016 Jun 13. Review.

50.

Renal allograft thrombosis after living donor transplantation: risk factors and obstacles to retransplantation.

Adler JT, Markmann JF, Yeh H.

Clin Transplant. 2016 Aug;30(8):864-71. doi: 10.1111/ctr.12750. Epub 2016 Jul 9.

PMID:
27101358

Supplemental Content

Loading ...
Support Center